$11.79
▼ -1.6% Today
as of Jul 22, 16:47 ET
Last 30 days
Recent Press Releases & News
Are Options Traders Betting on a Big Move in Core Laboratory Stock?
Core Stock Down 39% in 6 Months: Should You Hold or Sell Now?
BofA Securities Adjusts Core Laboratories Price Target to $11 From $12
Overview
52-week range
$9.72
$20
19% of range
Avg surprise (last 2)
-20.6%
Avg reaction (last 2)
+2.1%
50% positive
Latest IV / EM
63%
EM ±14.4% · $13 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Mar 31, 2026 | Mar 2026 | $-0.02 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $0.30 | — | — | — | — | financials |
| Wed Jul 23, 2025 | Jun/2025 | $0.19 | $0.18 | +5.6% | — | +7.2% | earnings |
| Wed Apr 23, 2025 | Mar/2025 | $0.08 | $0.15 | -46.7% | — | -3.0% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.25 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.19 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.07 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.19 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.48 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Jul 29, 2026 | Jun/2026 | AMC | $0.08 | $0.19 | -57.9% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $122M | — | $135M | $130M | $124M | — | $134M | $131M |
| Cost of revenue | $102M | — | $105M | $104M | $99M | — | $107M | $103M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $2M | — | $21M | $15M | $4M | — | $20M | $16M |
| Net income | $-789,000 | — | $14M | $11M | $-154,000 | — | $12M | $9M |
| EPS (diluted) | $-0.02 | — | $0.30 | $0.22 | — | — | $0.25 | $0.19 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $23M | $23M | $26M | $31M | $22M | $19M | $21M | $18M |
| Inventory | $58M | $54M | $58M | $60M | $59M | $59M | $65M | $70M |
| Total current assets | $214M | $215M | $227M | $238M | $229M | $227M | $235M | $234M |
| Total assets | $588M | $584M | $591M | $602M | $586M | $590M | $600M | $598M |
| Long-term debt | $114M | $110M | $114M | $125M | $124M | $126M | $140M | $148M |
| Total liabilities | — | — | — | — | — | — | — | — |
| Total equity | $269M | $266M | $271M | $261M | $253M | $252M | $251M | $240M |